loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 203519 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 MORPHINE SULFATE (1)

filter

01 TRIS PHARMA INC (1)

filter

01 SOLUTION;ORAL (1)

filter

01 20MG/5ML (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;ORAL
20MG/5ML
MORPHINE SULFATE
USA
203519
2016-05-18
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203519

Looking for CTD TGA MCC DOSSIER APPLICATION 203519 1

19

Tris Pharma Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is MORPHINE SULFATE, with a corresponding application number 203519 and regulatory information .

proudly manufactured in the

approval since 2016-05-18

Tris Pharma Inc's MORPHINE SULFATE SOLUTION;ORAL, medication with 20MG/5ML of MORPHINE SULFATE.

Post Enquiry
POST ENQUIRY